Cargando…
Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study
BACKGROUND: Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic patients and dyslipidemia, is associated with cardiac valve regurgitation. METHODS: We conducted a case-control study. Eligible patients were those admitted in the cardiol...
Autores principales: | Frachon, Irène, Etienne, Yves, Jobic, Yannick, Le Gal, Grégoire, Humbert, Marc, Leroyer, Christophe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853566/ https://www.ncbi.nlm.nih.gov/pubmed/20405030 http://dx.doi.org/10.1371/journal.pone.0010128 |
Ejemplares similares
-
Benfluorex withdrawal in France: Still be hiding somewhere in the world?
por: Frachon, Irène, et al.
Publicado: (2011) -
Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex?
por: Le Ven, Florent, et al.
Publicado: (2016) -
Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report
por: Baufreton, Christophe, et al.
Publicado: (2017) -
Echocardiographic Evidence for Valvular Toxicity of Benfluorex: A Double-Blind Randomised Trial in Patients with Type 2 Diabetes Mellitus
por: Derumeaux, Geneviève, et al.
Publicado: (2012) -
Sub-aortic obstruction of left ventricular outflow tract secondary to benfluorex-induced endocardial fibrosis
por: Szymanski, Catherine, et al.
Publicado: (2015)